Scientific Sessions 2024  /  Cardiometabolic Factors: Global Burden and Innovative Solutions  /  A New Era of Innovative Antihypertensive Treatment
Logo

American Heart Association

  2
  0

Final ID:

A New Era of Innovative Antihypertensive Treatment

  • Wang, Jiguang  ( , Shanghai , China )
    • Author Disclosures:
    Jiguang Wang: DO have relevant financial relationships ; Speaker:Novartis:Active (exists now) ; Speaker:Viatris:Active (exists now) ; Speaker:Servier:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Cardiometabolic Factors: Global Burden and Innovative Solutions

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Global Roundtable

More abstracts on this topic:
GREHTA: Success of a Mexican Initiative to reduce Hypertension Complications

Chavez Mendoza Adolfo

Priorities for Improving Cardiometabolic Health in the Americas

Piskorz Daniel

More abstracts from these authors:
Impact of arterial stiffness on the blood pressure lowering effect of the dual endothelin antagonist aprocitentan in patients with resistant hypertension

Schlaich Markus, Bakris George, Flack John, Danaietash Parisa, Sassi-sayadi Mouna, Narkiewicz Krzysztof, Wang Jiguang, Weber Michael

Efficacy and safety of aprocitentan in patients with resistant hypertension and elevated NT-proBNP

Weber Michael, Bakris George, Gimona Alberto, Narkiewicz Krzysztof, Schlaich Markus, Sassi-sayadi Mouna, Wang Jiguang, Flack John

You have to be authorized to contact abstract author. Please, Login
Not Available